Alaska Permanent Fund’s AGNC Investment AGNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-281,217
Closed -$2.48M 24
2025
Q1
$2.48M Hold
281,217
0.03% 233
2024
Q4
$2.59M Hold
281,217
0.04% 236
2024
Q3
$2.94M Hold
281,217
0.04% 213
2024
Q2
$2.81M Buy
281,217
+21,745
+8% +$208K 0.04% 224
2024
Q1
$2.57M Buy
259,472
+16,837
+7% +$162K 0.04% 249
2023
Q4
$2.38M Buy
242,635
+4,535
+2% +$39.9K 0.04% 266
2023
Q3
$2.25M Hold
238,100
0.04% 232
2023
Q2
$2.41M Buy
+238,100
New +$2.31M 0.05% 203
2022
Q4
$2.17M Hold
209,700
0.04% 223
2022
Q3
$1.77M Hold
209,700
0.03% 246
2022
Q2
$2.32M Buy
209,700
+73,400
+54% +$870K 0.03% 141
2022
Q1
$1.79M Hold
136,300
0.03% 197
2021
Q4
$2.03M Hold
136,300
0.04% 196
2021
Q3
$2.15M Hold
136,300
0.04% 183
2021
Q2
$2.3M Sell
136,300
-20,100
-13% -$357K 0.04% 188
2021
Q1
$2.62M Hold
156,400
0.05% 186
2020
Q4
$2.44M Hold
156,400
0.04% 179
2020
Q3
$2.18M Buy
156,400
+128,900
+469% +$1.77M 0.03% 134
2020
Q2
$355K Hold
27,500
0.01% 227
2020
Q1
$291K Buy
+27,500
New +$459K 0.01% 226

Other funds holding AGNC

Alaska Permanent Fund's AGNC Position: Q2 2025 in Review

Alaska Permanent Fund sold out of AGNC Investment (AGNC) in Q2 2025, closing a stake of 281,217 shares — an estimated $2.48M sold.

Alaska Permanent Fund first reported a position in AGNC in Q1 2020 and held it in 20 quarters. The position peaked at $2.94M in Q3 2024. 568 funds tracked by Wall St. Rank hold AGNC as of Q2 2025.

  • Alaska Permanent Fund reported no remaining AGNC Investment position as of Q2 2025 after selling out during the quarter.
  • Alaska Permanent Fund sold 281,217 AGNC Investment shares in Q2 2025, an estimated $2.48M.
  • Alaska Permanent Fund first reported a position in AGNC Investment in Q1 2020 and held it in 20 quarters.
  • Alaska Permanent Fund's AGNC Investment position peaked at $2.94M in Q3 2024.
  • 568 funds tracked by Wall St. Rank held AGNC Investment as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.